Palantir Technologies Inc. - Class A Common Stock (PLTR)
179.01
+0.00 (0.00%)
NASDAQ· Last Trade: Aug 14th, 7:59 AM EDT
Detailed Quote
Previous Close
179.01
Open
-
Bid
178.36
Ask
178.49
Day's Range
N/A - N/A
52 Week Range
106.37 - 207.52
Volume
318,354
Market Cap
362.94B
PE Ratio (TTM)
288.73
EPS (TTM)
0.6
Dividend & Yield
N/A (N/A)
1 Month Average Volume
45,648,596
Chart
About Palantir Technologies Inc. - Class A Common Stock (PLTR)
Palantir Technologies is a public software company that specializes in big data analytics and provides platforms for organizations to integrate, visualize, and analyze large amounts of data from disparate sources. Its flagship products, Palantir Gotham and Palantir Foundry, are designed to assist government agencies and commercial enterprises in making data-driven decisions by offering advanced analytical capabilities, collaborative tools, and visualization features. The company has gained prominence for its work with intelligence and defense organizations, as well as its growing presence in various industries such as finance, healthcare, and manufacturing, enabling clients to derive actionable insights and enhance their operational efficiency. Read More
Radian Group has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 12.6% to $36....
What Happened? Shares of rigid packaging solutions manufacturer Silgan Holdings (NYSE:SLGN) jumped 3.6% in the afternoon session after RBC Capital Markets up...
What Happened? A number of stocks jumped in the afternoon session after the Bureau of Labor Statistics reported that the July Producer Price Index was comple...
Palantir's AI opportunity is expanding rapidly, but its valuation still demands exceptional results. See which growth drivers could shape the stock's next chapter.
Voyager Technologies won a Space Force contract for space-to-space communications, boosting its defense credentials, backlog, and revenue growth, despite steep cash burn and a stretched valuation.
In today's rapidly changing and fiercely competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze companies. In this article, we will conduct a comprehensive
Inovio Pharmaceuticals (NASDAQ:INO) said the U.S. Food and Drug Administration has completed several key steps in its review of the company’s biologics license application for INO-3107, an investigational treatment for recurrent respiratory papillomatosis, or RRP, while the company continues prepara
Cisco Systems (NASDAQ:CSCO) reported record fourth-quarter and fiscal 2026 results, citing broad demand for networking, AI infrastructure, security and collaboration products. The company also issued fiscal 2027 guidance that calls for continued revenue and earnings growth as it pursues what Chief E
